Mitochondrial Dysfunction and Acute Fatty Liver of Pregnancy
- PMID: 35408956
- PMCID: PMC8999031
- DOI: 10.3390/ijms23073595
Mitochondrial Dysfunction and Acute Fatty Liver of Pregnancy
Abstract
The liver is one of the richest organs in mitochondria, serving as a hub for key metabolic pathways such as β-oxidation, the tricarboxylic acid (TCA) cycle, ketogenesis, respiratory activity, and adenosine triphosphate (ATP) synthesis, all of which provide metabolic energy for the entire body. Mitochondrial dysfunction has been linked to subcellular organelle dysfunction in liver diseases, particularly fatty liver disease. Acute fatty liver of pregnancy (AFLP) is a life-threatening liver disorder unique to pregnancy, which can result in serious maternal and fetal complications, including death. Pregnant mothers with this disease require early detection, prompt delivery, and supportive maternal care. AFLP was considered a mysterious illness and though its pathogenesis has not been fully elucidated, molecular research over the past two decades has linked AFLP to mitochondrial dysfunction and defects in fetal fatty-acid oxidation (FAO). Due to deficient placental and fetal FAO, harmful 3-hydroxy fatty acid metabolites accumulate in the maternal circulation, causing oxidative stress and microvesicular fatty infiltration of the liver, resulting in AFLP. In this review, we provide an overview of AFLP and mitochondrial FAO followed by discussion of how altered mitochondrial function plays an important role in the pathogenesis of AFLP.
Keywords: acute fatty liver of pregnancy; liver; long chain 3-hydroxyacyl Co-A; mitochondrial dysfunction; mitochondrial trifunctional protein; β-oxidation.
Conflict of interest statement
All authors declare no conflict of interest.
Figures



Similar articles
-
Liver injury in acute fatty liver of pregnancy: possible link to placental mitochondrial dysfunction and oxidative stress.Hepatology. 2010 Jan;51(1):191-200. doi: 10.1002/hep.23245. Hepatology. 2010. PMID: 20034024
-
Role of 3-Hydroxy Fatty Acid-Induced Hepatic Lipotoxicity in Acute Fatty Liver of Pregnancy.Int J Mol Sci. 2018 Jan 22;19(1):322. doi: 10.3390/ijms19010322. Int J Mol Sci. 2018. PMID: 29361796 Free PMC article. Review.
-
Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications.World J Gastroenterol. 2006 Dec 14;12(46):7397-404. doi: 10.3748/wjg.v12.i46.7397. World J Gastroenterol. 2006. PMID: 17167825 Free PMC article. Review.
-
Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease.JAMA. 2002 Nov 6;288(17):2163-6. doi: 10.1001/jama.288.17.2163. JAMA. 2002. PMID: 12413376
-
Liver disease in pregnancy and fetal fatty acid oxidation defects.Mol Genet Metab. 2000 Sep-Oct;71(1-2):182-9. doi: 10.1006/mgme.2000.3065. Mol Genet Metab. 2000. PMID: 11001809 Review.
Cited by
-
Acute liver failure in pregnancy.Indian J Gastroenterol. 2024 Apr;43(2):325-337. doi: 10.1007/s12664-024-01571-9. Epub 2024 May 1. Indian J Gastroenterol. 2024. PMID: 38691240 Review.
-
Maternal and umbilical cord plasma purine concentrations after oral carbohydrate loading prior to elective Cesarean delivery under spinal anesthesia: a randomized controlled trial.BMC Pregnancy Childbirth. 2025 May 10;25(1):556. doi: 10.1186/s12884-025-07637-6. BMC Pregnancy Childbirth. 2025. PMID: 40348958 Free PMC article. Clinical Trial.
-
Association between serum albumin and 42-day postpartum mortality in women with acute fatty liver of pregnancy: a retrospective study.Front Med (Lausanne). 2025 Jun 2;12:1574686. doi: 10.3389/fmed.2025.1574686. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40529137 Free PMC article.
-
Suppressing MTERF3 inhibits proliferation of human hepatocellular carcinoma via ROS-mediated p38 MAPK activation.Commun Biol. 2024 Jan 5;7(1):18. doi: 10.1038/s42003-023-05664-7. Commun Biol. 2024. PMID: 38177713 Free PMC article.
-
The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress.Int J Mol Sci. 2023 Oct 16;24(20):15212. doi: 10.3390/ijms242015212. Int J Mol Sci. 2023. PMID: 37894893 Free PMC article. Review.
References
-
- Patterson R.E., Kalavalapalli S., Williams C.M., Nautiyal M., Mathew J.T., Martinez J., Reinhard M.K., McDougall D.J., Rocca J.R., Yost R.A., et al. Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity. Am. J. Physiol. Endocrinol. Metab. 2016;310:E484–E494. doi: 10.1152/ajpendo.00492.2015. - DOI - PMC - PubMed
-
- Satapati S., Sunny N.E., Kucejova B., Fu X., He T.T., Méndez-Lucas A., Shelton J.M., Perales J.C., Browning J.D., Burgess S.C. Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. J. Lipid Res. 2012;53:1080–1092. doi: 10.1194/jlr.M023382. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous